z-logo
open-access-imgOpen Access
Loss of human epidermal receptor-2 in human epidermal receptor-2+ breast cancer after neoadjuvant treatment: A case report
Author(s) -
Jihong Yu,
Nanlin Li
Publication year - 2022
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v10.i17.5923
Subject(s) - medicine , immunohistochemistry , breast cancer , radiation therapy , biopsy , metastatic breast cancer , human epidermal growth factor receptor 2 , oncology , cancer , neoadjuvant therapy , targeted therapy , adjuvant therapy , trastuzumab , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here